SureTrader
Interactive Brokers Advertisement
Home > Boards > US OTC > Medical - Drugs >

Intiva Biopharma Inc. (KDRHD)

KDRHD RSS Feed
Add KDRHD Price Alert      Hide Sticky   Hide Intro
Moderator: FELLER, High_Profits, GOIN/Green
Search This Board: 
Last Post: 12/18/2017 2:54:03 PM - Followers: 38 - Board type: Free - Posts Today: 3

Intiva Biopharma Inc.

Stock Symbol = KDRHD and soon to be = NTVA 



https://www.intivabiopharma.com/


 
INTIVA BioPharma Inc. is a potentially disruptive drug development company
focused on cannabinoid-based pharmaceutical solutions.

 
 
The Company is researching and developing drug and cannabinoid molecules
for various medical conditions and diseases.  
ArcView Market Research estimates that
America's pharmaceutical cannabis sector could reach over $23 billion by 2020. 
 
 

INTIVA’S DRUG DEVELOPMENT ACTIVITIES

INTIVA’s drug development strategy consists of:

1. The determination of medical conditions and disorders that could potentially benefit from cannabinoid-based formulations;

2. Conducting “freedom to operate” investigations on these conditions;

3. The preparation of patent applications and the prosecution of such application and/or the licensing of existing patents;

4. Identifying the regulatory pathway with the U.S. Food and Drug Administration (FDA); and

5. Proceeding with clinical studies and clinical trials under FDA protocols for submission to obtain approval for the drug(s).

 

Because of the federal illegality of cannabis in the United States,
INTIVA is focusing its initial drug development using
 synthetic cannabinoids,
some of which are approved by the FDA for various medical conditions.

Synthetic cannabinoids generally simplify research development in the U.S.
However, INTIVA also intends to proceed with trials using plant-derived cannabinoids.
Because of the difficulty in proceeding with those trials in the United States,
the INTIVA will likely proceed with those trials in jurisdictions where the research is legal, such as Israel.

 

Jeffrey Friedland, Chief Executive Officer, and Director

Jeffrey Friedland is the Chief Executive Officer of the Company. He is also the Chief Executive Officer and Chairman of the Board of INTIVA Inc., https://www.intiva.us/  and has served in those positions since the inception of the Company in February 2014.  He also is a co-founder of the INTIVA Inc.

Mr. Friedland is a founder of Israel-based, Israel Plant Sciences Ltd., a company that is participating in Israel’s innovative agriculture and medicinal plant sectors and other agricultural related technologies, with a primary focus on cannabis.  Mr. Friedland is also a director of CannRx a US-based company with its principal operations in Israel that is researching the medical benefits of cannabis-based pharmaceuticals. 

In addition,  Jeff is on the Board of Advisors of OWC Pharmaceutical Research Corp.  http://www.owcpharma.com/  [symbol : OWCP]  an Israeli Medical Research company doing real Marajuana Medical Research and Clinical Trials in Israel.   Link to Clinical Trial ... 
http://tinyurl.com/ycgallvw

 

In his recently-published second book, "Marijuana: the World's Most Misunderstood Plant",
Mr. Friedland dives into the world of marijuana, discussing the history of the plant,
what we know and what we still hope to discover.   


View it on Amazon Books ... 
http://tinyurl.com/ybsttnwn

Since 1981, Mr. Friedland has provided investment banking, merchant banking, and corporate finance advisory services to hundreds of privately-held and listed companies worldwide.  These services have included obtaining venture capital and private equity capital, mergers and acquisitions, and assistance to companies regarding financing their growth and becoming stock market listed on stock exchanges worldwide.   Mr. Friedland has been the chief executive officer and a director of a NASDAQ-listed financial services company, a director, and chairman of the audit committee of a New York Stock Exchange-listed company, and chairman of a company listed on the EU-regulated market of the Frankfurt Stock Exchange.

 

He is an author, speaker and thought leader on emerging markets, the global economy, and the cannabis industry. He has been featured or quoted in numerous publications including the Wall Street Journal, Reuters, the New York Times, USA Today, the South China Morning Post, the Guam Daily Post, Bloomberg, the Forward, the Jewish Week, Quartz, the Jakarta Globe, Israel Daily Television, BreitBart,  NBC.com and Forbes.

 

Jeffrey Friedland's personal website for his link to his book, his articles and videos: www.jeffreyfriedland.com
 

____________________________________

Recent INVTIVA BIOPHARMA INC. SEC FILINGS
____________________________________

https://www.otcmarkets.com/stock/KDRHD/filings

Shares O/S Approx 44 Million 


_________________________________________

Recent Company NEWS
_________________________________________

Intiva BioPharma Submits a Request to the FDA for a Pre-Investigational New Drug Meeting
for a Pharmaceutical Product for Use in the Acute Treatment During and Immediately Following Exposure to Nerve Agents


https://www.intivabiopharma.com/intiva-biopharma-news




_______________________________________________________________________

Corporate VIDEO with Dr. Joseph Morgan
_______________________________________________________________________

"The Use of Cannabinoids as a Preventative and Therapy
for Exposure to Organophosphates and Nerve Agents Such as Sarin Gas"


https://www.intivabiopharma.com/videos  


_______________________________________________________________________

Corporate VIDEO with CEO Jeffrey Friedland
_______________________________________________________________________

In this episode we continue our series on the emerging legal cannabis industry
and will be speaking with industry expert, investor and speaker,
Mr. Jeffrey Friedland who is also author of the book,
Marijuana: The World’s Most Misunderstood Plant


https://www.youtube.com/watch?v=fu-9B9bN_kM&feature=youtu.be



NEW Intiva Biopharma Investor Relations Announced 
Mark Lubchenco 
Phone =  (303) 431-4530 
Email = mlubchenco@intiva.us,  ir@intiva.us 


TEMP STOCK SYMBOL = KDRHD 
NEW STOCK SYMBOL = NTVA [changes approx Dec 26th, 2017] 


Like & Follow Intiva Biopharma on Social Media 

Facebook

https://www.facebook.com/IntivaBiopharma/

Twitter
https://twitter.com/IntivaBiopharma


 
SureTrader
Interactive Brokers Advertisement
KDRHD
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
PostSubject
#1193  Sticky Note New CEO Interview [VIDEO] with Jeff Friedland - High_Profits 12/06/17 08:56:27 AM
#1242   JF knows how to add value to a surfgreen 12/18/17 02:54:03 PM
#1241   Large 1.76 bid and smaller one at 2.50 Quintessence 12/18/17 02:23:57 PM
#1240   Bid at 2.90 now. Decent volume. Quintessence 12/18/17 11:10:32 AM
#1239   I'm actually hoping to attend this year as FELLER 12/17/17 10:49:46 PM
#1238   More and more progress. It's only a matter FELLER 12/17/17 10:48:44 PM
#1237   Nice find. That'll be good exposure for Quintessence 12/15/17 01:44:23 PM
#1236   $NTVA $KDRHD I just registered to see @Jeff_Friedland High_Profits 12/15/17 12:58:39 PM
#1235   This is a great company with sound science GOIN/Green 12/15/17 09:17:07 AM
#1234   U.S. Surgeon General Says He Supports Medical Cannabis Research High_Profits 12/15/17 08:08:28 AM
#1233   Ohhh, man. Can't wait for the day after FELLER 12/14/17 09:35:19 PM
#1232   News might come much quicker then we know Farmer7 12/13/17 10:13:14 PM
#1231   Sorry It was probably me that misunderstood , Gonfishun 12/13/17 03:42:19 PM
#1230   Sorry, I think I misunderstood your question. I stockfan100 12/13/17 03:19:23 PM
#1229   Hi there...There is really nothing to PM. stockfan100 12/13/17 03:14:25 PM
#1228   Please pm me some of the others Gonfishun 12/13/17 02:51:11 PM
#1227   That is right. And, that is why stockfan100 12/13/17 02:34:37 PM
#1226   This is a good company and I am stockfan100 12/13/17 02:31:52 PM
#1225   Medical Marijuana Has No Health Risks, World Health High_Profits 12/13/17 01:48:27 PM
#1224   Which filing are you referring to? I Quintessence 12/13/17 01:48:19 PM
#1223   Per filing millions of free shares will be stockfan100 12/13/17 01:37:07 PM
#1222   Bid moving up a little. Won't take Quintessence 12/13/17 12:16:00 PM
#1221   I expect to see a lot of shares stockfan100 12/13/17 10:07:35 AM
#1220   If you want shares, you'll have to pay up Renegades17 12/13/17 09:02:39 AM
#1219   If wanted shares, I'd want in prior to BigBlackDog 12/13/17 07:31:41 AM
#1218   I placed an order but took a day Expresso123 12/13/17 07:09:59 AM
#1217   Probably I missed this train. Or have I? Sonuwa 12/13/17 06:38:06 AM
#1216   Nice read. Thanks for posting that article. Yeah STOCKPICKER4LIFE 12/13/17 05:53:02 AM
#1215   Articles like this make me believe there will Farmer7 12/12/17 08:26:23 PM
#1214   I don't know why somebody would sell "right FELLER 12/11/17 07:19:08 PM
#1213   $KDRHD $NTVA @IntivaBiopharma @jeff_friedlandIntiva Biopharma Inc. added, shanak10 12/11/17 12:10:57 PM
#1212   No sellers Period Any News will Be Blue Skies Stay High_Profits 12/10/17 01:48:28 PM
#1211   Yes sir, I'm sure after the ticker is Farmer7 12/10/17 12:45:37 PM
#1210   Let's just say that the "free" float is Renegades17 12/10/17 09:52:08 AM
#1209   New ticker, a couple PRs and we're off BigBlackDog 12/10/17 07:57:44 AM
#1208   I talked to the T.A. yesterday.. O.S. is 43,789,888 STOCKPICKER4LIFE 12/09/17 11:42:15 PM
#1207   jeff_friedland $KDRHD $NTVA @IntivaBiopharma $OWCP @OWCPharma https://youtu.be High_Profits 12/09/17 02:02:30 PM
#1206   I agree. Exciting things on the horizon! Quintessence 12/09/17 10:47:33 AM
#1205   There's some pretty savy investors here. Shares will Farmer7 12/09/17 08:50:47 AM
#1204   Float: 14M, OS: 43.5M according to OwnTheFLoat. Quintessence 12/08/17 03:55:17 PM
#1203   Intiva BioPharma CEO @jeff_friedland High_Profits 12/08/17 01:06:18 PM
#1202   After the split what is the FLOAT and Orangeman3 12/08/17 10:52:57 AM
#1201   Great interview, as always. FELLER 12/07/17 11:26:38 PM
#1200   Bid moving up. A 2.25 break could Quintessence 12/07/17 01:11:03 PM
#1199   UPDATED Intiva WebSite High_Profits 12/07/17 11:20:23 AM
#1198   Yup. Little bit of Ask slapping today. Quintessence 12/07/17 11:17:48 AM
#1197   $KDRHD moving along nicely. Name change soon. shanak10 12/07/17 11:15:45 AM
#1196   Ramping up their social media exposure. Nice! Quintessence 12/07/17 09:18:56 AM
#1195   Like Intiva Biopharma on Social Media High_Profits 12/07/17 08:19:05 AM
#1194   Interview with @jeff_friedland of @IntivaBiopharma $KDRHD $NTVA High_Profits 12/06/17 02:22:11 PM
#1193   New CEO Interview [VIDEO] with Jeff Friedland - High_Profits 12/06/17 08:56:27 AM
PostSubject